Advancing engineering design strategies for targeted cancer nanomedicine

References

Matsumura, Y. & Maeda, H. A new concept for macromolecular therapeutics in cancer-chemotherapy – mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46, 6387–6392 (1986). This seminal paper illustrates the EPR effect, demonstrating high macromolecule accumulation in tumours.

Google Scholar
Maeda, H., Wu, J., Sawa, T., Matsumura, Y. & Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Rel. 65, 271–284 (2000).

Google Scholar
Lahooti, B. et al. Targeting endothelial permeability in the EPR effect. J. Control. Rel. 361, 212–235 (2023).

Google Scholar
Sharifi, M. et al. An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment. Cancers 14, 2868 (2022).

Google Scholar
Bertrand, N., Wu, J., Xu, X. Y., Kamaly, N. & Farokhzad, O. C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 66, 2–25 (2014).

Google Scholar
Zuckerman, J. E. & Davis, M. E. Clinical experiences with systemically administered siRNA-based therapeutics in cancer. Nat. Rev. Drug Discov. 14, 843–856 (2015).

Google Scholar
Davis, M. E., Chen, Z. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771–782 (2008).

Google Scholar
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A. & Davis, M. E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl Acad. Sci. USA 104, 15549–15554 (2007).

Google Scholar
Harrington, K. J. et al. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br. J. Cancer 83, 232–238 (2000).

Google Scholar
Dai, Q. et al. Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors. ACS Nano 12, 8423–8435 (2018). This work investigates the physical and cellular barriers to intratumoural transport of passive and ligand-targeted nanoparticles and ultimate delivery to cancer cells after intravenous administration.

Google Scholar
Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).

Google Scholar
Kingston, B. R. et al. Specific endothelial cells govern nanoparticle entry into solid tumors. ACS Nano 15, 14080–14094 (2021).

Google Scholar
Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566–575 (2020).

Google Scholar
Tavares, A. J. et al. Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc. Natl Acad. Sci. USA 114, E10871–E10880 (2017).

Google Scholar
Bae, Y. H. & Park, K. Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Rel. 153, 198–205 (2011).

Google Scholar
Feng, X. et al. Opportunities and challenges for inhalable nanomedicine formulations in respiratory diseases: a review. Int. J. Nanomed. 19, 1509–1538 (2024).

Google Scholar
Khang, M. et al. Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma. Sci. Transl. Med. 15, eadi1617 (2023).

Google Scholar
De Andres, J. et al. Intrathecal drug delivery: advances and applications in the management of chronic pain patient. Front. Pain Res. 3, 900566 (2022).

Google Scholar
Niu, L., Chu, L. Y., Burton, S. A., Hansen, K. J. & Panyam, J. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response. J. Control. Rel. 294, 268–278 (2019).

Google Scholar
Correa, S. et al. Tuning nanoparticle interactions with ovarian cancer through layer-by-layer modification of surface chemistry. ACS Nano 14, 2224–2237 (2020).

Google Scholar
Gao, N. et al. Tumor penetrating theranostic nanoparticles for enhancement of targeted and image-guided drug delivery into peritoneal tumors following intraperitoneal delivery. Theranostics 7, 1689–1704 (2017).

Google Scholar
Wright, A. A. et al. Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer. J. Clin. Oncol. 33, 2841–2847 (2015).

Google Scholar
Palugan, L. et al. Intravesical drug delivery approaches for improved therapy of urinary bladder diseases. Int. J. Pharm. X 3, 100100 (2021).

Google Scholar
Yoon, H. Y. et al. Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer. Expert Opin. Drug Deliv. 17, 1555–1572 (2020).

Google Scholar
Yun, W. S. et al. Recent studies and progress in the intratumoral administration of nano-sized drug delivery systems. Nanomaterials 13, 2225 (2023).

Google Scholar
Talebian, S. et al. Biopolymers for antitumor implantable drug delivery systems: recent advances and future outlook. Adv. Mater. 30, 1706665 (2018).

Google Scholar
Lan, X. et al. Microneedle-mediated delivery of lipid-coated cisplatin nanoparticles for efficient and safe cancer therapy. ACS Appl. Mater. Interfaces 10, 33060–33069 (2018).

Google Scholar
Moradi Kashkooli, F., Jakhmola, A., Hornsby, T. K., Tavakkoli, J. & Kolios, M. C. Ultrasound-mediated nano drug delivery for treating cancer: fundamental physics to future directions. J. Control. Rel. 355, 552–578 (2023).

Google Scholar
Wang, Y. et al. Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance. Nat. Biomed. Eng. 5, 1048–1058 (2021).

Google Scholar
D’Amico, R. S., Aghi, M. K., Vogelbaum, M. A. & Bruce, J. N. Convection-enhanced drug delivery for glioblastoma: a review. J. Neurooncol. 151, 415–427 (2021).

Google Scholar
Pickering, A. J. et al. Layer-by-layer polymer functionalization improves nanoparticle penetration and glioblastoma targeting in the brain. ACS Nano 17, 24154–24169 (2023).

Google Scholar
Wicki, A., Witzigmann, D., Balasubramanian, V. & Huwyler, J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J. Control. Rel. 200, 138–157 (2015).

Google Scholar
Hoshyar, N., Gray, S., Han, H. & Bao, G. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11, 673–692 (2016).

Google Scholar
Longmire, M., Choyke, P. L. & Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3, 703–717 (2008).

Google Scholar
Magnussen, A. L. & Mills, I. G. Vascular normalisation as the stepping stone into tumour microenvironment transformation. Br. J. Cancer 125, 324–336 (2021).

Google Scholar
Mpekris, F. et al. Combining microenvironment normalization strategies to improve cancer immunotherapy. Proc. Natl Acad. Sci. USA 117, 3728–3737 (2020).

Google Scholar
Hartl, N., Adams, F. & Merkel, O. M. From adsorption to covalent bonding: apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier. Adv. Ther. 4, 2000092 (2021).

Google Scholar
Brown, T. D., Habibi, N., Wu, D., Lahann, J. & Mitragotri, S. Effect of nanoparticle composition, size, shape, and stiffness on penetration across the blood–brain barrier. ACS Biomater. Sci. Eng. 6, 4916–4928 (2020).

Google Scholar
Chen, S. et al. Effect of cationic charge density on transcytosis of polyethylenimine. Biomacromolecules 22, 5139–5150 (2021).

Google Scholar
Lamson, N. G. et al. Trafficking through the blood–brain barrier is directed by core and outer surface components of layer-by-layer nanoparticles. Bioeng. Transl. Med. 9, e10636 (2024).

Google Scholar
Kreuter, J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv. Drug Deliv. Rev. 71, 2–14 (2014).

Google Scholar
Wiley, D. T., Webster, P., Gale, A. & Davis, M. E. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc. Natl Acad. Sci. USA 110, 8662–8667 (2013).

Google Scholar
Georgieva, J. V. et al. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro. Mol. Ther. 19, 318–325 (2011).

Google Scholar
Saucier-Sawyer, J. K. et al. Distribution of polymer nanoparticles by convection-enhanced delivery to brain tumors. J. Control. Rel. 232, 103–112 (2016).

Google Scholar
Biddlestone-Thorpe, L. et al. Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents. Adv. Drug Deliv. Rev. 64, 605–613 (2012).

Google Scholar
Curtis, C., Toghani, D., Wong, B. & Nance, E. Colloidal stability as a determinant of nanoparticle behavior in the brain. Colloids Surf. B Biointerfaces 170, 673–682 (2018).

Google Scholar
Jiang, X., Zhao, H. & Li, W. Microneedle-mediated transdermal delivery of drug-carrying nanoparticles. Front. Bioeng. Biotechnol. 10, 840395 (2022).

Google Scholar
Koenitz, L., Crean, A. & Vucen, S. Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics. Eur. J. Pharm. Biopharm. 204, 114517 (2024).

Google Scholar
Wang, J. C. et al. Microneedles-mediated intradermal delivery of paclitaxel/anti-PD-1 for efficient and safe triple-negative breast cancer therapy. Adv. Ther. 7, 2300362 (2024).

Google Scholar
Schudel, A., Francis, D. M. & Thomas, S. N. Material design for lymph node drug delivery. Nat. Rev. Mater. 4, 415–428 (2019).

Google Scholar
Yousefpour, P., Ni, K. & Irvine, D. J. Targeted modulation of immune cells and tissues using engineered biomaterials. Nat. Rev. Bioeng. 1, 107–124 (2023).

Google Scholar
Ceelen, W. P. & Flessner, M. F. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat. Rev. Clin. Oncol. 7, 108–115 (2010).

Google Scholar
Dakwar, G. R. et al. Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — mission possible? Adv. Drug Deliv. Rev. 108, 13–24 (2017).

Google Scholar
Aznar, M. A. et al. Intratumoral delivery of immunotherapy — act locally, think globally. J. Immunol. 198, 31–39 (2017).

Google Scholar
Champiat, S. et al. Intratumoral immunotherapy: from trial design to clinical practice. Clin. Cancer Res. 27, 665–679 (2021).

Google Scholar
Huang, A. et al. Human intratumoral therapy: linking drug properties and tumor transport of drugs in clinical trials. J. Control. Rel. 326, 203–221 (2020).

Google Scholar
Hamid, O., Ismail, R. & Puzanov, I. Intratumoral immunotherapy — update 2019. Oncologist 25, e423–e438 (2019).

Google Scholar
Holback, H. & Yeo, Y. Intratumoral drug delivery with nanoparticulate carriers. Pharm. Res. 28, 1819–1830 (2011).

Google Scholar
J. Saadh, M. et al. Nanoparticle-based targeting of pancreatic tumor stroma and extracellular matrix: a promising approach for improved treatment. J. Drug Deliv. Sci. Technol. 99, 105938 (2024).

Google Scholar
Herrera, V. L. M. et al. Evaluation of expansile nanoparticle tumor localization and efficacy in a cancer stem cell-derived model of pancreatic peritoneal carcinomatosis. Nanomedicine 11, 1001–1015 (2016).

Google Scholar
Zhang, B. et al. Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles. Biomaterials 35, 4088–4098 (2014).

Google Scholar
Passos, J. S., Lopes, L. B. & Panitch, A. Collagen-binding nanoparticles for paclitaxel encapsulation and breast cancer treatment. ACS Biomater. Sci. Eng. 9, 6805–6820 (2023).

Google Scholar
Chaib, M., Chauhan, S. C. & Makowski, L. Friend or foe? recent strategies to target myeloid cells in cancer. Front. Cell Dev. Biol. 8, 351 (2020).

Google Scholar
Vu-Quang, H. et al. Carboxylic mannan-coated iron oxide nanoparticles targeted to immune cells for lymph node-specific MRI in vivo. Carbohydr. Polym. 88, 780–788 (2012).

Google Scholar
Hudgins, P. A., Anzai, Y., Morris, M. R. & Lucas, M. A. Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. Am. J. Neuroradiol. 23, 649–656 (2002).

Google Scholar
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).

Google Scholar
Xu, L. et al. Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors. J. Hematol. Oncol. 15, 87 (2022). This review illustrates the complex role of the tumour immune environment and therapeutic strategies to modulate said environment to promote anticancer responses.

Google Scholar
Zhang, C. et al. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy. J. Control. Rel. 256, 170–181 (2017).

Google Scholar
Xu, Y. et al. Mannan-decorated pathogen-like polymeric nanoparticles as nanovaccine carriers for eliciting superior anticancer immunity. Biomaterials 284, 121489 (2022).

Google Scholar
Cao, Y. et al. Dendritic cell-mimicking nanoparticles promote mrna delivery to lymphoid organs. Adv. Sci. 10, 2302423 (2023).

Google Scholar
Mortara, L. et al. Anti-cancer therapies employing IL-2 cytokine tumor targeting: contribution of innate, adaptive and immunosuppressive cells in the anti-tumor efficacy. Front. Immunol. 9, 2905 (2018).

Google Scholar
Chu, J. et al. Natural killer cells: a promising immunotherapy for cancer. J. Transl. Med. 20, 240 (2022).

Google Scholar
Laumont, C. M., Banville, A. C., Gilardi, M., Hollern, D. P. & Nelson, B. H. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414–430 (2022).

Google Scholar
Saw, P. E., Chen, J. & Song, E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer 8, 527–555 (2022). This review describes the role of CAFs in tumour progression and therapeutic strategies that are utilized to target this cell population.

Google Scholar
Xiao, Z. & Puré, E. The fibroinflammatory response in cancer. Nat. Rev. Cancer 25, 399–425 (2025).

Google Scholar
Zheng, A., Wei, Y., Zhao, Y., Zhang, T. & Ma, X. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer. Front. Immunol. 13, 1013506 (2022).

Google Scholar
Huang, H. et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell 40, 656–673.e657 (2022).

Google Scholar
Zhao, Y. et al. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma. Proc. Natl Acad. Sci. USA 116, 2210–2219 (2019).

Google Scholar
Zhang, Y., Wu, J. L., Lazarovits, J. & Chan, W. C. An analysis of the binding function and structural organization of the protein corona. J. Am. Chem. Soc. 142, 8827–8836 (2020).

Google Scholar
Corbo, C. et al. Unveiling the in vivo protein corona of circulating leukocyte-like carriers. ACS Nano 11, 3262–3273 (2017).

Google Scholar
Grunér, M. S., Kauscher, U., Linder, M. & Monopoli, M. An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma. J. Proteom. 137, 52–58 (2016).

Google Scholar
Mosquera, J., García, I., Henriksen-Lacey, M., González-Rubio, G. & Liz-Marzán, L. M. Reducing protein corona formation and enhancing colloidal stability of gold nanoparticles by capping with silica monolayers. Chem. Mater. 31, 57–61 (2018).

Google Scholar
Hadjidemetriou, M., Al-Ahmady, Z. & Kostarelos, K. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles. Nanoscale 8, 6948–6957 (2016).

Google Scholar
Xiao, W. & Gao, H. The impact of protein corona on the behavior and targeting capability of nanoparticle-based delivery system. Int. J. Pharm. 552, 328–339 (2018).

Google Scholar
Lazarovits, J. et al. Supervised learning and mass spectrometry predicts the in vivo fate of nanomaterials. ACS Nano 13, 8023–8034 (2019).

Google Scholar
Ngo, W. et al. Identifying cell receptors for the nanoparticle protein corona using genome screens. Nat. Chem. Biol. 18, 1023–1031 (2022).

Google Scholar
Montizaan, D. et al. Genome-wide forward genetic screening to identify receptors and proteins mediating nanoparticle uptake and intracellular processing. Nat. Nanotechnol. 19, 1022–1031 (2024). This work identified cell receptors, including lipoprotein receptors and glycosaminoglycans, implicated in nanoparticle uptake, through a genome-wide screening.

Google Scholar
Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J. & Kraft, M. L. Protein corona significantly reduces active targeting yield. Chem. Commun. 49, 2557–2559 (2013).

Google Scholar
Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8, 137–143 (2013).

Google Scholar
Wang, H. et al. Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined. ACS Nano 14, 14779–14789 (2020).

Google Scholar
Xiao, W. et al. Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. Int. J. Pharm. 538, 105–111 (2018).

Google Scholar
Bilardo, R., Traldi, F., Vdovchenko, A. & Resmini, M. Influence of surface chemistry and morphology of nanoparticles on protein corona formation. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 14, e1788 (2022).

Google Scholar
Barz, M., Parak, W. J. & Zentel, R. Concepts and approaches to reduce or avoid protein corona formation on nanoparticles: challenges and opportunities. Adv. Sci. 11, 2402935 (2024).

Google Scholar
Dilliard, S. A., Cheng, Q. & Siegwart, D. J. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc. Natl Acad. Sci. USA 118, e2109256118 (2021).

Google Scholar
Chen, D., Parayath, N., Ganesh, S., Wang, W. & Amiji, M. The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models. Nanoscale 11, 18806–18824 (2019).

Google Scholar
Caracciolo, G. et al. Human biomolecular corona of liposomal doxorubicin: the overlooked factor in anticancer drug delivery. ACS Appl. Mater. Interfaces 10, 22951–22962 (2018).

Google Scholar
Papi, M. et al. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. Nanoscale 9, 10327–10334 (2017).

Google Scholar
Gao, Y., Joshi, M., Zhao, Z. & Mitragotri, S. PEGylated therapeutics in the clinic. Bioeng. Transl. Med. 9, e10600 (2024). This review presents the range of investigational and clinically approved PEGylated therapeutics, PEG engineering strategies and challenges.

Google Scholar
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A. & Chan, W. C. W. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134, 2139–2147 (2012).

Google Scholar
Chen, D., Ganesh, S., Wang, W. & Amiji, M. The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles. Nanoscale 11, 8760–8775 (2019).

Google Scholar
Pozzi, D. et al. Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. Nanoscale 6, 2782–2792 (2014).

Google Scholar
Ju, Y. et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano 16, 11769–11780 (2022).

Google Scholar
Besin, G. et al. Accelerated blood clearance of lipid nanoparticles entails a biphasic humoral response of B-1 followed by B-2 lymphocytes to distinct antigenic moieties. Immunohorizons 3, 282–293 (2019). This study demonstrates the accelerated blood clearance of repeat doses of intravenous PEGylated lipid nanoparticles and illustrates a B cell-driven response.

Google Scholar
Wang, X., Ishida, T. & Kiwada, H. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J. Control. Rel. 119, 236–244 (2007).

Google Scholar
Wang, H. et al. Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats. npj Vaccines 8, 169 (2023).

Google Scholar
Schöttler, S. et al. Protein adsorption is required for stealth effect of poly (ethylene glycol)-and poly (phosphoester)-coated nanocarriers. Nat. Nanotechnol. 11, 372–377 (2016).

Google Scholar
Overby, C., Park, S., Summers, A. & Benoit, D. S. W. Zwitterionic peptides: tunable next-generation stealth nanoparticle modifications. Bioact. Mater. 27, 113–124 (2023).

Google Scholar
García, K. P. et al. Zwitterionic-coated “stealth” nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small 10, 2516–2529 (2014).

Google Scholar
Müller, J. et al. Coating nanoparticles with tunable surfactants facilitates control over the protein corona. Biomaterials 115, 1–8 (2017).

Google Scholar
Simon, J. et al. Noncovalent targeting of nanocarriers to immune cells with polyphosphoester-based surfactants in human blood plasma. Adv. Sci. 6, 1901199 (2019). This study demonstrates the multifunctional design of polymers serving as a nanoparticle surface chemistry to increase targeting to specific cells and also reduce nonspecific uptake by off-target cells.

Google Scholar
Sarparanta, M. et al. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Mol. Pharm. 9, 654–663 (2012).

Google Scholar
Moghimi, S. M., Muir, I., Illum, L., Davis, S. S. & Kolb-Bachofen, V. Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta Mol. Cell Res. 1179, 157–165 (1993).

Google Scholar
Shi, D. et al. To PEGylate or not to PEGylate: immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives. Adv. Drug Deliv. Rev. 180, 114079 (2022).

Google Scholar
Hui, Y. et al. Role of nanoparticle mechanical properties in cancer drug delivery. ACS Nano 13, 7410–7424 (2019). This review presents how mechanical properties of nanoparticles affect uptake and distribution, highlighting other physiochemical properties of nanoparticles that have a role in their trafficking.

Google Scholar
Kong, S. M., Costa, D. F., Jagielska, A., Vliet, K. J. V. & Hammond, P. T. Stiffness of targeted layer-by-layer nanoparticles impacts elimination half-life, tumor accumulation, and tumor penetration. Proc. Natl Acad. Sci. USA 118, e2104826118 (2021).

Google Scholar
Sykes, E. A., Chen, J., Zheng, G. & Chan, W. C. W. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8, 5696–5706 (2014).

Google Scholar
Cong, V. T. et al. Can the shape of nanoparticles enable the targeting to cancer cells over healthy cells? Adv. Funct. Mater. 31, 2007880 (2021).

Google Scholar
Elci, S. G. et al. Surface charge controls the suborgan biodistributions of gold nanoparticles. ACS Nano 10, 5536–5542 (2016).

Google Scholar
Zelepukin, I. V. et al. Fast processes of nanoparticle blood clearance: comprehensive study. J. Control. Rel. 326, 181–191 (2020).

Google Scholar
Anselmo, A. C. et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9, 3169–3177 (2015).

Google Scholar
Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505–515 (2008).

Google Scholar
Guo, P. et al. Nanoparticle elasticity directs tumor uptake. Nat. Commun. 9, 130 (2018).

Google Scholar
Marques, A. C., Costa, P. J., Velho, S. & Amaral, M. H. Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies. J. Control. Rel. 320, 180–200 (2020).

Google Scholar
Chen, F. et al. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nat. Commun. 9, 4141 (2018).

Google Scholar
Schau, I. et al. Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis. Sci. Rep. 9, 3299 (2019).

Google Scholar
Zhang, C. et al. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody–DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer. Sci. Rep. 10, 22015 (2020).

Google Scholar
Dissanayake, S., Denny, W. A., Gamage, S. & Sarojini, V. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. J. Control. Rel. 250, 62–76 (2017).

Google Scholar
Wu, X., Chen, J., Wu, M. & Zhao, J. X. Aptamers: active targeting ligands for cancer diagnosis and therapy. Theranostics 5, 322–344 (2015).

Google Scholar
Farran, B. et al. Folate-conjugated nanovehicles: strategies for cancer therapy. Mater. Sci. Eng. C 107, 110341 (2020).

Google Scholar
Koneru, T. et al. Transferrin: biology and use in receptor-targeted nanotherapy of gliomas. ACS Omega 6, 8727–8733 (2021).

Google Scholar
Kizhakkanoodan, K. S., Rallapalli, Y., Praveena, J., Acharya, S. & Guru, B. R. Cancer nanomedicine: emergence, expansion, and expectations. SN Appl. Sci. 5, 385 (2023).

Google Scholar
Ly, P.-D. et al. Recent advances in surface decoration of nanoparticles in drug delivery. Front. Nanotechnol. 6, 1456939 (2024).

Google Scholar
Richardson, J. J. et al. Innovation in layer-by-layer assembly. Chem. Rev. 116, 14828–14867 (2016).

Google Scholar
Such, G. K., Johnston, A. P. R. & Caruso, F. Engineered hydrogen-bonded polymer multilayers: from assembly to biomedical applications. Chem. Soc. Rev. 40, 19–29 (2011).

Google Scholar
Monge, C., Almodovar, J., Boudou, T. & Picart, C. Spatio-temporal control of LbL films for biomedical applications: from 2D to 3D. Adv. Healthc. Mater. 4, 811–830 (2015).

Google Scholar
Morton, S. W., Poon, Z. & Hammond, P. T. The architecture and biological performance of drug-loaded LbL nanoparticles. Biomaterials 34, 5328–5335 (2013).

Google Scholar
Boyer, C. et al. Glycopolymer decoration of gold nanoparticles using a LbL approach. Macromolecules 43, 3775–3784 (2010).

Google Scholar
Peng, Q. et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34, 8521–8530 (2013).

Google Scholar
Dal Magro, R. et al. Artificial apolipoprotein corona enables nanoparticle brain targeting. Nanomed. Nanotechnol. Biol. Med. 14, 429–438 (2018).

Google Scholar
Kim, J. et al. Engineered biomimetic nanoparticle for dual targeting of the cancer stem-like cell population in sonic hedgehog medulloblastoma. Proc. Natl Acad. Sci. USA 117, 24205–24212 (2020).

Google Scholar
Caracciolo, G. et al. Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles. ACS Appl. Mater. Interfaces 5, 13171–13179 (2013).

Google Scholar
Tonigold, M. et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. Nat. Nanotechnol. 13, 862–869 (2018). This work demonstrates that nanoparticles with non-covalently adsorbed antibodies outperform those with covalently attached antibodies at targeting, even upon protein corona formation.

Google Scholar
Lv, H., Zhang, S., Wang, B., Cui, S. & Yan, J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Rel. 114, 100–109 (2006).

Google Scholar
Fröhlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 7, 5577–5591 (2012).

Google Scholar
Sekar, R. P. et al. Poly(l-glutamic acid) augments the transfection performance of lipophilic polycations by overcoming tradeoffs among cytotoxicity, pDNA delivery efficiency, and serum stability. RSC Appl. Polym. 2, 701–718 (2024).

Google Scholar
Wang, C. et al. Poly(α-glutamic acid) combined with polycation as serum-resistant carriers for gene delivery. Int. J. Pharm. 398, 237–245 (2010).

Google Scholar
Boehnke, N., Dolph, K. J., Juarez, V. M., Lanoha, J. M. & Hammond, P. T. Electrostatic conjugation of nanoparticle surfaces with functional peptide motifs. Bioconjug. Chem. 31, 2211–2219 (2020).

Google Scholar
Gessner, I., Klimpel, A., Klußmann, M., Neundorf, I. & Mathur, S. Interdependence of charge and secondary structure on cellular uptake of cell penetrating peptide functionalized silica nanoparticles. Nanoscale Adv. 2, 453–462 (2020).

Google Scholar
Conte, C. et al. Non-covalent strategies to functionalize polymeric nanoparticles with NGR peptides for targeting breast cancer. Int. J. Pharm. 633, 122618 (2023).

Google Scholar
Lesley, J., Hascall, V. C., Tammi, M. & Hyman, R. Hyaluronan binding by cell surface CD44. J. Biol. Chem. 275, 26967–26975 (2000).

Google Scholar
Dubacheva, G. V., Curk, T., Auzély-Velty, R., Frenkel, D. & Richter, R. P. Designing multivalent probes for tunable superselective targeting. Proc. Natl Acad. Sci. USA 112, 5579–5584 (2015).

Google Scholar
Passos Gibson, V. et al. Hyaluronan decorated layer-by-layer assembled lipid nanoparticles for miR-181a delivery in glioblastoma treatment. Biomaterials 302, 122341 (2023).

Google Scholar
Sacks, J. D. & Barbolina, M. V. Expression and function of CD44 in epithelial ovarian carcinoma. Biomolecules 5, 3051–3066 (2015).

Google Scholar
Mattheolabakis, G., Milane, L., Singh, A. & Amiji, M. M. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J. Drug Target. 23, 605–618 (2015).

Google Scholar
Almalik, A. et al. Hyaluronic acid coated chitosan nanoparticles reduced the immunogenicity of the formed protein corona. Sci. Rep. 7, 10542 (2017).

Google Scholar
Martens, T. F. et al. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy. J. Control. Rel. 202, 83–92 (2015).

Google Scholar
Tian, H. et al. Uniform core–shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv. Healthc. Mater. 7, 1800285 (2018).

Google Scholar
Zhou, M. et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv. 25, 716–722 (2018).

Google Scholar
Nabar, N., Dacoba, T. G., Covarrubias, G., Romero-Cruz, D. & Hammond, P. T. Electrostatic adsorption of polyanions onto lipid nanoparticles controls uptake, trafficking, and transfection of RNA and DNA therapies. Proc. Natl Acad. Sci. USA 121, e2307809121 (2024).

Google Scholar
Dreaden, E. C. et al. Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles. ACS Nano 8, 8374–8382 (2014).

Google Scholar
Deiss-Yehiely, E. et al. Surface presentation of hyaluronic acid modulates nanoparticle-cell association. Bioconjug. Chem. 33, 2065–2075 (2022). This work investigates the impact of nanoparticle surface modification with covalent versus adsorbed polymer as well as polymer architecture on cell association.

Google Scholar
Vasić, K. et al. Structural and magnetic characteristics of carboxymethyl dextran coated magnetic nanoparticles: from characterization to immobilization application. React. Funct. Polym. 148, 104481 (2020).

Google Scholar
Huang, B. et al. Amphoteric natural starch-coated polymer nanoparticles with excellent protein corona-free and targeting properties. Nanoscale 12, 5834–5847 (2020).

Google Scholar
Min, K. A., Yu, F., Yang, V. C., Zhang, X. & Rosania, G. R. Transcellular transport of heparin-coated magnetic iron oxide nanoparticles (Hep-MION) under the influence of an applied magnetic field. Pharmaceutics 2, 119–135 (2010).

Google Scholar
Geijtenbeek, T. B. H. & Gringhuis, S. I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465–479 (2009).

Google Scholar
Vu-Quang, H. et al. Immune cell-specific delivery of beta-glucan-coated iron oxide nanoparticles for diagnosing liver metastasis by MR imaging. Carbohydr. Polym. 87, 1159–1168 (2012).

Google Scholar
Kalia, N., Singh, J. & Kaur, M. The role of dectin-1 in health and disease. Immunobiology 226, 152071 (2021).

Google Scholar
Harisinghani, M. G. et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N. Engl. J. Med. 348, 2491–2499 (2003).

Google Scholar
Raynal, I. et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Investig. Radiol. 39, 56–63 (2004).

Google Scholar
Cambi, A. & Figdor, C. G. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 15, 539–546 (2003).

Google Scholar
Lee, R. T. et al. Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities. Glycobiology 21, 512–520 (2011).

Google Scholar
Chen, F., Huang, G. & Huang, H. Sugar ligand-mediated drug delivery. Future Med. Chem. 12, 161–171 (2020).

Google Scholar
Calvaresi, E. C. & Hergenrother, P. J. Glucose conjugation for the specific targeting and treatment of cancer. Chem. Sci. 4, 2319–2333 (2013).

Google Scholar
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).

Google Scholar
Saini, K. & Bandyopadhyaya, R. Transferrin-conjugated polymer-coated mesoporous silica nanoparticles loaded with gemcitabine for killing pancreatic cancer cells. ACS Appl. Nano Mater. 3, 229–240 (2020).

Google Scholar
Stevens, D. M. et al. Application of a scavenger receptor A1-targeted polymeric prodrug platform for lymphatic drug delivery in HIV. Mol. Pharm. 17, 3794–3812 (2020).

Google Scholar
Sun, C. et al. Polymeric nanomedicine with “Lego” surface allowing modular functionalization and drug encapsulation. ACS Appl. Mater. Interfaces 10, 25090–25098 (2018).

Google Scholar
Kim, S. et al. Cucurbit[6]uril-based polymer nanocapsules as a non-covalent and modular bioimaging platform for multimodal in vivo imaging. Mater. Horiz. 4, 450–455 (2017).

Google Scholar
Fang, R. H., Gao, W. & Zhang, L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat. Rev. Clin. Oncol. 20, 33–48 (2023).

Google Scholar
Hu, C.-M. J. et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526, 118–121 (2015).

Google Scholar
Ren, X. et al. Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials 92, 13–24 (2016).

Google Scholar
Rao, L. et al. Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl. Mater. Interfaces 9, 2159–2168 (2017). This study demonstrated that erythrocyte membrane coatings on nanoparticles notably reduce protein adsorption and preserve the targeting abilities of other surface ligands.

Google Scholar
Hu, C.-M. J. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980–10985 (2011).

Google Scholar
Parodi, A. et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat. Nanotechnol. 8, 61–68 (2013).

Google Scholar
Pitchaimani, A. et al. Biomimetic natural killer membrane camouflaged polymeric nanoparticle for targeted bioimaging. Adv. Funct. Mater. 29, 1806817 (2019).

Google Scholar
Cao, H. et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 10, 7738–7748 (2016).

Google Scholar
Kang, T. et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano 11, 1397–1411 (2017).

Google Scholar
Chen, Z. et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano 10, 10049–10057 (2016).

Google Scholar
Zhu, J.-Y. et al. Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett. 16, 5895–5901 (2016).

Google Scholar
Liu, Z. et al. Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo. Proc. Natl Acad. Sci. USA 118, e2022769118 (2021).

Google Scholar
Ma, X. et al. Tumor–antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma. ACS Nano 17, 2341–2355 (2023).

Google Scholar
Fang, R. H. et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 14, 2181–2188 (2014).

Google Scholar
Kou, L. et al. Transporter-guided delivery of nanoparticles to improve drug permeation across cellular barriers and drug exposure to selective cell types. Front. Pharmacol. 9, 27 (2018).

Google Scholar
de Almeida, M. S. et al. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem. Soc. Rev. 50, 5397–5434 (2021).

Google Scholar
Behzadi, S. et al. Cellular uptake of nanoparticles: journey inside the cell. Chem. Soc. Rev. 46, 4218–4244 (2017). This review discusses nanoparticle uptake and intracellular trafficking, and explores the impact of nanoparticle size, hydrophobicity, surface charge and functionality.

Google Scholar
Rennick, J. J., Johnston, A. P. & Parton, R. G. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat. Nanotechnol. 16, 266–276 (2021). This review presents advances in understanding cellular uptake of nanoparticles and discusses limitations and alternatives to experimental approaches to study endocytosis.

Google Scholar
Chakraborty, A. & Jana, N. R. Clathrin to lipid raft-endocytosis via controlled surface chemistry and efficient perinuclear targeting of nanoparticle. J. Phys. Chem. Lett. 6, 3688–3697 (2015).

Google Scholar
Rewatkar, P. V., Parton, R. G., Parekh, H. S. & Parat, M.-O. Are caveolae a cellular entry route for non-viral therapeutic delivery systems? Adv. Drug Deliv. Rev. 91, 92–108 (2015).

Google Scholar
Hong, E. et al. Structure and composition define immunorecognition of nucleic acid nanoparticles. Nano Lett. 18, 4309–4321 (2018).

Google Scholar
França, A. et al. Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro. Nanomedicine 6, 1175–1188 (2011).

Google Scholar
Cai, H., Liang, Z., Huang, W., Wen, L. & Chen, G. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery. Int. J. Pharm. 532, 55–65 (2017).

Google Scholar
Tan, X. et al. Cell-penetrating peptide together with PEG-modified mesostructured silica nanoparticles promotes mucous permeation and oral delivery of therapeutic proteins and peptides. Biomater. Sci. 7, 2934–2950 (2019).

Google Scholar
Margus, H., Arukuusk, P., Langel, U. & Pooga, M. Characteristics of cell-penetrating peptide/nucleic acid nanoparticles. Mol. Pharm. 13, 172–179 (2016).

Google Scholar
He, Z. et al. Scalable production of core–shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin. Nanoscale 10, 3307–3319 (2018).

Google Scholar
Dalal, C. & Jana, N. R. Galactose multivalency effect on the cell uptake mechanism of bioconjugated nanoparticles. J. Phys. Chem. C 122, 25651–25660 (2018).

Google Scholar
Dalal, C., Saha, A. & Jana, N. R. Nanoparticle multivalency directed shifting of cellular uptake mechanism. J. Phys. Chem. C 120, 6778–6786 (2016).

Google Scholar
Moradi, E., Vllasaliu, D., Garnett, M., Falcone, F. & Stolnik, S. Ligand density and clustering effects on endocytosis of folate modified nanoparticles. RSC Adv. 2, 3025–3033 (2012).

Google Scholar
Abstiens, K., Gregoritza, M. & Goepferich, A. M. Ligand density and linker length are critical factors for multivalent nanoparticle–receptor interactions. ACS Appl. Mater. Interfaces 11, 1311–1320 (2018).

Google Scholar
Cao, J. et al. The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles. Colloids Surf. B Biointerfaces 161, 508–518 (2018).

Google Scholar
Ye, Z. et al. Tumour‐targeted drug delivery with mannose‐functionalized nanoparticles self‐assembled from amphiphilic β‐cyclodextrins. Chemistry 22, 15216–15221 (2016).

Google Scholar
Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172–176 (2010).

Google Scholar
Cullis, P. R. & Hope, M. J. Lipid nanoparticle systems for enabling gene therapies. Mol. Ther. 25, 1467–1475 (2017).

Google Scholar
Kube, S. et al. Fusogenic liposomes as nanocarriers for the delivery of intracellular proteins. Langmuir 33, 1051–1059 (2017).

Google Scholar
Ermilova, I. & Swenson, J. DOPC versus DOPE as a helper lipid for gene-therapies: molecular dynamics simulations with DLin-MC3-DMA. Phys. Chem. Chem. Phys. 22, 28256–28268 (2020).

Google Scholar
Parodi, A. et al. Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers. Nanomedicine 10, 1923–1940 (2015).

Google Scholar
Kodama, Y. et al. Quaternary complexes modified from pDNA and poly-l-lysine complexes to enhance pH-buffering effect and suppress cytotoxicity. J. Pharm. Sci. 104, 1470–1477 (2015).

Google Scholar
Kim, J., Kang, Y., Tzeng, S. Y. & Green, J. J. Synthesis and application of poly(ethylene glycol)-co-poly (β-amino ester) copolymers for small cell lung cancer gene therapy. Acta Biomater. 41, 293–301 (2016).

Google Scholar
Pan, L., Liu, J. & Shi, J. Cancer cell nucleus-targeting nanocomposites for advanced tumor therapeutics. Chem. Soc. Rev. 47, 6930–6946 (2018).

Google Scholar
Yue, Z.-G. et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12, 2440–2446 (2011).

Google Scholar
Li, N. et al. Nuclear-targeted siRNA delivery for long-term gene silencing. Chem. Sci. 8, 2816–2822 (2017).

Google Scholar
Pan, L., Liu, J., He, Q. & Shi, J. MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression. Adv. Mater. 26, 6742–6748 (2014).

Google Scholar
Tabish, T. A. & Hamblin, M. R. Mitochondria-targeted nanoparticles (mitoNANO): an emerging therapeutic shortcut for cancer. Biomater. Biosyst. 3, 100023 (2021).

Google Scholar
Chakraborty, A. & Jana, N. R. Design and synthesis of triphenylphosphonium functionalized nanoparticle probe for mitochondria targeting and imaging. J. Phys. Chem. C 119, 2888–2895 (2015).

Google Scholar
Chen, S. et al. Mitochondria-targeting “Nanoheater” for enhanced photothermal/chemo-therapy. Biomaterials 117, 92–104 (2017).

Google Scholar
Acharya, S. & Hill, R. A. High efficacy gold-KDEL peptide-siRNA nanoconstruct-mediated transfection in C2C12 myoblasts and myotubes. Nanomed. Nanotechnol. Biol. Med. 10, 329–337 (2014).

Google Scholar
Shi, N.-Q., Li, Y., Zhang, Y., Li, Z.-Q. & Qi, X.-R. Deepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines. Int. J. Nanomed. 13, 5537–5559 (2018).

Google Scholar
Chen, L. et al. Cascade delivery to golgi apparatus and on‐site formation of subcellular drug reservoir for cancer metastasis suppression. Small 19, 2204747 (2023).

Google Scholar
Chen, L. et al. Exocytosis blockade of endoplasmic reticulum-targeted nanoparticle enhances immunotherapy. Nano Today 42, 101356 (2022).

Google Scholar
Li, H. et al. Chondroitin sulfate-linked prodrug nanoparticles target the Golgi apparatus for cancer metastasis treatment. Acs Nano 13, 9386–9396 (2019).

Google Scholar
Luo, J., Gong, T. & Ma, L. Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management. Carbohydr. Polym. 249, 116887 (2020).

Google Scholar
Zhao, Y. et al. Integrating organoids and organ-on-a-chip devices. Nat. Rev. Bioeng. 2, 588–608 (2024).

Google Scholar
Astashkina, A. I. et al. Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model. Biomaterials 35, 6323–6331 (2014).

Google Scholar
Baek, A. et al. Novel organoid culture system for improved safety assessment of nanomaterials. Nano Lett. 24, 805–813 (2024).

Google Scholar
Zhang, Z., Rahmat, J. N., Mahendran, R. & Zhang, Y. Controllable assembly of upconversion nanoparticles enhanced tumor cell penetration and killing efficiency. Adv. Sci. 7, 2001831 (2020).

Google Scholar
Lu, M. et al. Protein absorption alters the cellular targeting of glycopolymeric nanoparticles. J. Drug Deliv. Sci. Technol. 102, 106334 (2024).

Google Scholar
Kumari, M., Acharya, A. & Krishnamurthy, P. T. Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics. Beilstein J. Nanotechnol. 14, 912–926 (2023).

Google Scholar
Tošić, I. et al. Lipidome-based targeting of STAT3-driven breast cancer cells using poly-l-glutamic acid-coated layer-by-layer nanoparticles. Mol. Cancer Ther. 20, 726–738 (2021).

Google Scholar
Camorani, S. et al. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies. J. Exp. Clin. Cancer Res. 43, 92 (2024).

Google Scholar
McCarthy, B., Cudykier, A., Singh, R., Levi-Polyachenko, N. & Soker, S. Semiconducting polymer nanoparticles for photothermal ablation of colorectal cancer organoids. Sci. Rep. 11, 1532 (2021).

Google Scholar
Ahn, S. I. et al. Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms. Nat. Commun. 11, 175 (2020).

Google Scholar
Straehla, J. P. et al. A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles. Proc. Natl Acad. Sci. USA 119, e2118697119 (2022).

Google Scholar
Lin, D. S. Y., Guo, F. & Zhang, B. Modeling organ-specific vasculature with organ-on-a-chip devices. Nanotechnology 30, 024002 (2019).

Google Scholar
Wang, H.-F. et al. Tumor-vasculature-on-a-chip for investigating nanoparticle extravasation and tumor accumulation. ACS Nano 12, 11600–11609 (2018). This work demonstrates the use of organ-on-a-chip platforms to evaluate the trafficking of nanoparticle formulations across biological barriers, specifically extravasation and the tumour extracellular matrix.

Google Scholar
Lu, R., Lee, B. J. & Lee, E. Three-dimensional lymphatics-on-a-chip reveals distinct, size-dependent nanoparticle transport mechanisms in lymphatic drug delivery. ACS Biomater. Sci. Eng. 10, 5752–5763 (2024).

Google Scholar
Sun, W. et al. Organ-on-a-chip for cancer and immune organs modeling. Adv. Healthc. Mater. 8, 1801363 (2019).

Google Scholar
Tian, C., Zheng, S., Liu, X. & Kamei, K.-i Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system. J. Nanobiotechnol. 20, 338 (2022).

Google Scholar
Li, L., Gokduman, K., Gokaltun, A., Yarmush, M. L. & Usta, O. B. A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles. Nanomedicine 14, 2209–2226 (2019).

Google Scholar
Skardal, A. et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci. Rep. 7, 8837 (2017).

Google Scholar
Ozkan, A., Ghousifam, N., Hoopes, P. J., Yankeelov, T. E. & Rylander, M. N. In vitro vascularized liver and tumor tissue microenvironments on a chip for dynamic determination of nanoparticle transport and toxicity. Biotechnol. Bioeng. 116, 1201–1219 (2019).

Google Scholar
Ronaldson-Bouchard, K. et al. A multi-organ chip with matured tissue niches linked by vascular flow. Nat. Biomed. Eng. 6, 351–371 (2022).

Google Scholar
Lin, Q., Fathi, P. & Chen, X. Nanoparticle delivery in vivo: a fresh look from intravital imaging. eBioMedicine 59, 102958 (2020).

Google Scholar
Miller, M. A. & Weissleder, R. Imaging the pharmacology of nanomaterials by intravital microscopy: toward understanding their biological behavior. Adv. Drug Deliv. Rev. 113, 61–86 (2017). This review explores the potential of intravital microscopy to study the barriers and mechanisms of nanoparticle trafficking and targeting in vivo.

Google Scholar
Peng, X., Wang, Y., Zhang, J., Zhang, Z. & Qi, S. Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy. Front. Immunol. 14, 1288273 (2023).

Google Scholar
Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1–7 (2024). This work screened libraries of lipid designs to identify potent candidates for nanoparticle-mediated delivery of mRNA, using machine learning and combinatorial chemistry tools.

Google Scholar
Kumar, R., Le, N., Oviedo, F., Brown, M. E. & Reineke, T. M. Combinatorial polycation synthesis and causal machine learning reveal divergent polymer design rules for effective pDNA and ribonucleoprotein delivery. JACS Au 2, 428–442 (2022).

Google Scholar
Ortiz-Perez, A., van Tilborg, D., van der Meel, R., Grisoni, F. & Albertazzi, L. Machine learning-guided high throughput nanoparticle design. Digit. Discov. 3, 1280–1291 (2024).

Google Scholar
Reker, D. et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nat. Nanotechnol. 16, 725–733 (2021).

Google Scholar
Liu, D. et al. A versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties. Adv. Mater. 27, 2298–2304 (2015).

Google Scholar
Medina, D. X. et al. Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo. J. Control. Rel. 253, 172–182 (2017).

Google Scholar
Willmore, A.-M. A. et al. Targeted silver nanoparticles for ratiometric cell phenotyping. Nanoscale 8, 9096–9101 (2016).

Google Scholar
Lokugamage, M. P., Sago, C. D. & Dahlman, J. E. Testing thousands of nanoparticles in vivo using DNA barcodes. Curr. Opin. Biomed. Eng. 7, 1–8 (2018).

Google Scholar
Yaari, Z. et al. Theranostic barcoded nanoparticles for personalized cancer medicine. Nat. Commun. 7, 13325 (2016).

Google Scholar
Dahlman, J. E. et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc. Natl Acad. Sci. USA 114, 2060–2065 (2017).

Google Scholar
Huayamares, S. G. et al. High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo. J. Control. Rel. 357, 394–403 (2023).

Google Scholar
Xue, L. et al. High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models. Nat. Commun. 15, 1884 (2024).

Google Scholar
Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).

Google Scholar
Lin, Z. et al. Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches. Int. J. Nanomed. 17, 1365–1379 (2022).

Google Scholar
Ban, Z. et al. Machine learning predicts the functional composition of the protein corona and the cellular recognition of nanoparticles. Proc. Natl Acad. Sci. USA 117, 10492–10499 (2020). This paper utilized machine learning models to predict protein corona compositions and cellular recognition patterns based on nanoparticle features, most notably surface chemistry.

Google Scholar
Boehnke, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 377, eabm5551 (2022). This study screened a library of nanoparticles varying in core and surface chemistry, in 488 pooled cancer cell lines, to identify genomic biomarkers associated with nanoparticle uptake.

Google Scholar
Kibria, M. R. et al. Predicting efficacy of drug-carrier nanoparticle designs for cancer treatment: a machine learning-based solution. Sci. Rep. 13, 547 (2023).

Google Scholar
Vora, L. K. et al. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics 15, 1916 (2023).

Google Scholar
Nevone, A. et al. SMaRT M-Seq: an optimized step-by-step protocol for M protein sequencing in monoclonal gammopathies. Biol. Methods Protoc. 9, bpae074 (2024).

Google Scholar
Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).

Google Scholar
Shi, J. P. et al. Construction and validation of transcription-factor-based prognostic signature for TACE non-response and characterization of tumor microenvironment infiltration in hepatocellular carcinoma. Oncol. Lett. 29, 42 (2025).

Google Scholar
You, M. Y. et al. HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis. Oncoimmunology 13, 2356942 (2024).

Google Scholar
Cilento, M. A., Sweeney, C. J. & Butler, L. M. Spatial transcriptomics in cancer research and potential clinical impact: a narrative review. J. Cancer Res. Clin. Oncol. 150, 296 (2024).

Google Scholar
Bollhagen, A. & Bodenmiller, B. Highly multiplexed tissue imaging in precision oncology and translational cancer research. Cancer Discov. 14, 2071–2088 (2024).

Google Scholar
Gulati, G. S., D’Silva, J. P., Liu, Y. H., Wang, L. H. & Newman, A. M. Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat. Rev. Mol. Cell Biol. 26, 11–31 (2025).

Google Scholar
Kurma, K., Eslami-S, Z., Alix-Panabieres, C. & Cayrefourcq, L. Liquid biopsy: paving a new avenue for cancer research. Cell Adhes. Migr. 18, 1–26 (2024).

Google Scholar
Ge, Q., Zhang, Z. Y., Li, S. N., Ma, J. Q. & Zhao, Z. Liquid biopsy: comprehensive overview of circulating tumor DNA (review). Oncol. Lett. 28, 548 (2024).

Google Scholar
Yao, J. et al. Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer. Hum. Vaccines Immunother. 20, 2406063 (2024).

Google Scholar
Sykes, E. A. et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc. Natl Acad. Sci. USA 113, E1142–E1151 (2016). This work demonstrates that the physical characteristics of the tumour impacts the accumulation of nanoparticles of varying size and surface modification, highlighting the consideration of tumour pathophysiology to guide nanomedicine design.

Google Scholar
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03774680 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02740985 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06589401 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03465618 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04240639 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00920023 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04784221 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04899908 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02766699 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06234098 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT01696084 (2020).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04083235 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03678883 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06389591 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04534205 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05497453 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT01593488 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT01645839 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00945724 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02393157 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00249990 (2010).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00102531 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05739981 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05285358 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04858009 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00666991 (2014).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00708864 (2014).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02106598 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04505267 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04862455 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06048367 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04314895 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03739931 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06249048 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03946800 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03101358 (2021).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04138342 (2019).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06169072 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03827967 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04951245 (2022).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03606967 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05232851 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT01507103 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT00291473 (2009).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05198752 (2022).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03897881 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06077760 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05533697 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT03480152 (2020).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02009332 (2021).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05519241 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06173349 (2024).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT04264143 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT06468605 (2025).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT02022644 (2023).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/study/NCT05864534 (2025).
Chenthamara, D. et al. Therapeutic efficacy of nanoparticles and routes of administration. Biomater. Res. 23, 20 (2019).

Google Scholar
Kim, K. S., Na, K. & Bae, Y. H. Nanoparticle oral absorption and its clinical translational potential. J. Control. Rel. 360, 149–162 (2023).

Google Scholar
Ruiz, M. E. & Scioli Montoto, S. in ADME Processes in Pharmaceutical Sciences: Dosage, Design, and Pharmacotherapy Success (eds Talevi, A. & Quiroga, P. A. M.) 97–133 (Springer, 2018).
Fowler, M. J. et al. Intrathecal drug delivery in the era of nanomedicine. Adv. Drug Deliv. Rev. 165-166, 77–95 (2020).

Google Scholar
Koo, J., Lim, C. & Oh, K. T. Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations. Int. J. Nanomed. 19, 1767–1807 (2024).

Google Scholar
Sharma, M. in Applications of Targeted Nano Drugs and Delivery Systems (eds Mohapatra, S. S. et al.) 499–550 (Elsevier, 2019).
Bruinsmann, F. A. et al. Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: preclinical and clinical trials. Molecules 24, 4312 (2019).

Google Scholar
Morales, D. E. & Mousa, S. Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities. Heliyon 8, e09517 (2022).

Google Scholar
Miele, E., Spinelli, G. P., Miele, E., Tomao, F. & Tomao, S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int. J. Nanomed. 4, 99–105 (2009).

Google Scholar
Hofstraat, S. R. J. et al. Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors. Nat. Nanotechnol. 20, 532–542 (2025).

Google Scholar
Barberio, A. E. et al. Cancer cell coating nanoparticles for optimal tumor-specific cytokine delivery. ACS Nano 14, 11238–11253 (2020).

Google Scholar
Paulino da Silva Filho, O. et al. A comparison of acyl-moieties for noncovalent functionalization of PLGA and PEG–PLGA nanoparticles with a cell-penetrating peptide. RSC Adv. 11, 36116–36124 (2021).

Google Scholar
Chen, W.-H. et al. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy. Biomaterials 117, 54–65 (2017).

Google Scholar
Men, W. et al. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo. Drug Deliv. 27, 180–190 (2020).

Google Scholar
Zhao, J. et al. Hyaluronic acid layer-by-layer (LbL) nanoparticles for synergistic chemo-phototherapy. Pharm. Res. 35, 196 (2018).

Google Scholar
Liu, R., Xiao, W., Hu, C., Xie, R. & Gao, H. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis. J. Control. Rel. 278, 127–139 (2018).

Google Scholar
Wang, T., Hou, J., Su, C., Zhao, L. & Shi, Y. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. J. Nanobiotechnol. 15, 7 (2017).

Google Scholar
Ramasamy, T. et al. Layer-by-layer coated lipid–polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr. Polym. 102, 653–661 (2014).

Google Scholar
Haddadi, A., Hamdy, S., Ghotbi, Z., Samuel, J. & Lavasanifar, A. Immunoadjuvant activity of the nanoparticles’ surface modified with mannan. Nanotechnology 25, 355101 (2014).

Google Scholar
Siddharth, S., Nayak, A., Nayak, D., Bindhani, B. K. & Kundu, C. N. Chitosan-dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage. Sci. Rep. 7, 2143 (2017).

Google Scholar
Wang, F., Li, J., Tang, X., Huang, K. & Chen, L. Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery. Colloids Surf. B Biointerfaces 190, 110925 (2020).

Google Scholar
Su, Y., Yang, F., Chen, L. & Cheung, P. C. K. Mushroom carboxymethylated β-d-glucan functions as a macrophage-targeting carrier for iron oxide nanoparticles and an inducer of proinflammatory macrophage polarization for immunotherapy. J. Agric. Food Chem. 70, 7110–7121 (2022).

Google Scholar
Singh, P. K. et al. 1,3β-Glucan anchored, paclitaxel loaded chitosan nanocarrier endows enhanced hemocompatibility with efficient anti-glioblastoma stem cells therapy. Carbohydr. Polym. 180, 365–375 (2018).

Google Scholar
Li, X. et al. Stable and biocompatible mushroom β-glucan modified gold nanorods for cancer photothermal therapy. J. Agric. Food Chem. 65, 9529–9536 (2017).

Google Scholar
Wu, H. et al. Hydroxyethyl starch stabilized polydopamine nanoparticles for cancer chemotherapy. Chem. Eng. J. 349, 129–145 (2018).

Google Scholar
Chai, F. et al. Doxorubicin-loaded poly(lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications. Int. J. Nanomed. 12, 1791–1802 (2017).

Google Scholar
Yuk, S. H. et al. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging. Biomacromolecules 12, 2335–2343 (2011).

Google Scholar
Manivasagan, P., Bharathiraja, S., Bui, N. Q., Lim, I. G. & Oh, J. Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells. Int. J. Pharm. 511, 367–379 (2016).

Google Scholar
Ma, H.-l, Qi, X.-r, Maitani, Y. & Nagai, T. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int. J. Pharm. 333, 177–186 (2007).

Google Scholar
Ghaffarlou, M. et al. Photothermal and radiotherapy with alginate-coated gold nanoparticles for breast cancer treatment. Sci. Rep. 14, 13299 (2024).

Google Scholar
Zhou, J. et al. Layer by layer chitosan/alginate coatings on poly(lactide-co-glycolide) nanoparticles for antifouling protection and folic acid binding to achieve selective cell targeting. J. Colloid Interface Sci. 345, 241–247 (2010).

Google Scholar
Boyle, W. S., Senger, K., Tolar, J. & Reineke, T. M. Heparin enhances transfection in concert with a trehalose-based polycation with challenging cell types. Biomacromolecules 18, 56–67 (2017).

Google Scholar
Delechiave, G. et al. Layer-by-layer assembly of polymeric nanoparticles with heparin-RBD Complexes as an adjuvant for SARS-CoV-2 protein-based vaccines. ACS Appl. Nano Mater. 7, 4068–4077 (2024).

Google Scholar
Yue, L. et al. Gold nanorods with a noncovalently tailorable surface for multi-modality image-guided chemo-photothermal cancer therapy. Chem. Commun. 55, 13506–13509 (2019).

Google Scholar
Yue, L., Sun, C., Kwong, C. H. T. & Wang, R. Cucurbit[7]uril-functionalized magnetic nanoparticles for imaging-guided cancer therapy. J. Mater. Chem. B 8, 2749–2753 (2020).

Google Scholar
Zheng, C. et al. In situ modification of the tumor cell surface with immunomodulating nanoparticles for effective suppression of tumor growth in mice. Adv. Mater. 31, 1902542 (2019).

Google Scholar
Yoo, M. K. et al. Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting. BioMed. Res. Int. 2007, 094740 (2007).

Google Scholar
Liu, G. et al. Engineering biomimetic platesomes for pH-responsive drug delivery and enhanced antitumor activity. Adv. Mater. 31, 1900795 (2019).

Google Scholar
Zhang, L. et al. Erythrocyte membrane cloaked metal-organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy. ACS Nano 12, 10201–10211 (2018).

Google Scholar
Nam, J. et al. Engineered polysaccharides for controlling innate and adaptive immune responses. Nat. Rev. Bioeng. 2, 733–751 (2024).

Google Scholar
Murphy, E. J. et al. Polysaccharides-naturally occurring immune modulators. Polymers 15, 2373 (2023).

Google Scholar
Yang, F. & Cheung, P. C. K. Fungal β-glucan-based nanotherapeutics: from fabrication to application. J. Fungi 9, 475 (2023).

Google Scholar

Download references

References

Related Posts

Advancing rheumatic disease care through generative artificial intelligence

Advancing in ovo egg sexing through molecular sex identification of chick embryos using LAMP and RPA assays